Pollinex Quattro Ragweed: Preliminary Phase II/III data

Preliminary data from the double-blind, placebo-controlled, Canadian Phase II/III R204 trial in 177 evaluable ragweed sensitive patients showed that 4 weekly subcutaneous injections of Pollinex Quattr...